The 340B Drug Pricing Program requires manufacturers to provide outpatient drugs to eligible health care organizations at discounted prices. This allows these organizations, also referred to as covered entities, to generate savings through reduced medication expenses and invest in programs that expand and enhance health services for patients and community members. These savings can be used to lower medication costs for patients; however, they also can be used to support patient care services that may not be otherwise be financially sustainable.  This session will provide foundational knowledge of the 340B Drug Pricing Program and then dive into two examples of how clinical pharmacy services were developed and sustained using 340B Program revenue.

This session is open to all meeting registrants and is part of the CMM and Billing and Contracting Academy programming.

Faculty

	Speaker: Adriane N. Irwin, Pharm.D., MS, FCCP, BCACP Associate Professor (Clinical), Oregon State University (OSU) College of Pharmacy and Chair, Department of Pharmacy Practice   View Biography
	Speaker: Andrew J. Sowles, Pharm.D., BCACP, BCPS Manager, Ambulatory Care Clinical Pharmacy Services Pharmacy Department, Salem Health
	Speaker: Stacy Ramirez, Pharm.D.